200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 100562-97-8
CAS No: 100562-97-8 Catalog No: AG0002CM MDL No:
Title | Journal |
---|---|
The combi-targeting concept: mechanism of action of the pleiotropic combi-molecule RB24 and discovery of a novel cell signaling-based combination principle. | Cellular signalling 20110401 |
Towards an efficient prodrug of the alkylating metabolite monomethyltriazene: synthesis and stability of N-acylamino acid derivatives of triazenes. | European journal of medicinal chemistry 20090301 |
Mechanism of action of a novel 'combi-triazene' engineered to possess a polar functional group on the alkylating moiety: evidence for enhancement of potency. | Biochemical pharmacology 20050815 |
[Expression of caspase 3 and p53 during physiological apoptosis and apoptosis induced by three teratologic agents during early craniofacial development of the mouse embryo]. | Morphologie : bulletin de l'Association des anatomistes 20050601 |
Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line. | British journal of cancer 20040913 |
A phase I (tumour site-specific) study of carboplatin and temozolomide in patients with advanced melanoma. | British journal of cancer 20031117 |
Two spin labeled triazenes: relationship between biochemical and biological activities. | International journal of pharmaceutics 20021024 |
© 2019 Angene International Limited. All rights Reserved.